The prognostic power of major pathological response in esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multi-center cohort study

BackgroundFor esophageal squamous cell carcinoma(ESCC), neoadjuvant chemoimmunotherapy (nICT) constitutes an innovative therapeutic strategy. However, The relationship between its short-term efficacy and long-term prognosis requires further clarification. Therefore, this study aims to evaluate the p...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuhan Xie, Shijie Huang, Zilu Tang, Hai Zhang, Jinxin Xu, Sunkui Ke, Jinbiao Xie, Rongyu Xu, Ying Chen, Zhinuan Hong, Mingqiang Kang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1599526/full
Tags: Add Tag
No Tags, Be the first to tag this record!